Literature DB >> 24523316

[Content validity and inter-rater reliability of the Cognitive Fluctuation Inventory].

Mamoru Hashimoto1, Yuta Manabe, Etsuro Mori, Nobutsugu Hirono, Kenji Kosaka, Manabu Ikeda.   

Abstract

OBJECTIVE: The Cognitive Fluctuation Inventory (CFI) was developed to evaluate cognitive fluctuation in patients with dementia with Lewy bodies (DLB). The objective of this study was to assess the content validity and inter-rater reliability of the CFI. SUBJECTS AND METHODS: Nine specialists in DLB treatment were invited to participate in the survey to assess the content validity of the CFI. They were asked to assess the relevance and comprehensibility of the question items. In the validation study, inter-rater reliability was assessed using the intraclass correlation coefficient (ICC).
RESULTS: Regarding content validity, all nine specialists considered the main question and sub-questions to be relevant to cognitive fluctuation in patients with DLB. Eight out of nine specialists considered the CFI to be a comprehensive measure for detecting cognitive fluctuation in patients with DLB. In the analysis, which used data from 29 patients and their caregivers, the ICC of the CFI was 0.746, which suggests good inter-rater reliability.
CONCLUSION: We found that the CFI showed good content validity and inter-rater reliability for evaluating cognitive fluctuation in patients with DLB.

Entities:  

Mesh:

Year:  2014        PMID: 24523316

Source DB:  PubMed          Journal:  Brain Nerve        ISSN: 1881-6096


  7 in total

Review 1.  Outcome Measures for Dementia With Lewy Body Clinical Trials: A Review.

Authors:  Bhavana Patel; David J Irwin; Daniel Kaufer; Bradley F Boeve; Angela Taylor; Melissa J Armstrong
Journal:  Alzheimer Dis Assoc Disord       Date:  2022 Jan-Mar 01       Impact factor: 2.357

2.  Unclassified fluent variants of primary progressive aphasia: distinction from semantic and logopenic variants.

Authors:  Hiroyuki Watanabe; Sakura Hikida; Manabu Ikeda; Etsuro Mori
Journal:  Brain Commun       Date:  2022-02-02

3.  Long-term donepezil use for dementia with Lewy bodies: results from an open-label extension of Phase III trial.

Authors:  Etsuro Mori; Manabu Ikeda; Reiko Nagai; Kazutaka Matsuo; Masaki Nakagawa; Kenji Kosaka
Journal:  Alzheimers Res Ther       Date:  2015-02-03       Impact factor: 6.982

4.  Donepezil for dementia with Lewy bodies: a randomized, placebo-controlled, confirmatory phase III trial.

Authors:  Manabu Ikeda; Etsuro Mori; Kazutaka Matsuo; Masaki Nakagawa; Kenji Kosaka
Journal:  Alzheimers Res Ther       Date:  2015-02-03       Impact factor: 6.982

5.  The Pareidolia Test: A Simple Neuropsychological Test Measuring Visual Hallucination-Like Illusions.

Authors:  Yasuyuki Mamiya; Yoshiyuki Nishio; Hiroyuki Watanabe; Kayoko Yokoi; Makoto Uchiyama; Toru Baba; Osamu Iizuka; Shigenori Kanno; Naoto Kamimura; Hiroaki Kazui; Mamoru Hashimoto; Manabu Ikeda; Chieko Takeshita; Tatsuo Shimomura; Etsuro Mori
Journal:  PLoS One       Date:  2016-05-12       Impact factor: 3.240

6.  Negative mood invites psychotic false perception in dementia.

Authors:  Hiroyuki Watanabe; Yoshiyuki Nishio; Yasuyuki Mamiya; Wataru Narita; Osamu Iizuka; Toru Baba; Atsushi Takeda; Tatsuo Shimomura; Etsuro Mori
Journal:  PLoS One       Date:  2018-06-01       Impact factor: 3.240

7.  A prospective multicenter validation study of a machine learning algorithm classifier on quantitative electroencephalogram for differentiating between dementia with Lewy bodies and Alzheimer's dementia.

Authors:  Yukiko Suzuki; Maki Suzuki; Kazue Shigenobu; Kazuhiro Shinosaki; Yasunori Aoki; Hirokazu Kikuchi; Toru Baba; Mamoru Hashimoto; Toshihiko Araki; Kristinn Johnsen; Manabu Ikeda; Etsuro Mori
Journal:  PLoS One       Date:  2022-03-31       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.